Disproportionality analysis of post-marketing safety concerns associated with selumetinib in the FDA adverse event reporting system

F Fengfen Liu H Huaiyu Su W Wei Wei

Article Details

Volume / Issue Vol. 15, Issue 1
Published March 17, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (3)

F

Fengfen Liu

H

Huaiyu Su

W

Wei Wei